Dr. Frances Shepherd CV - (NCRI) is
Dr. Frances Shepherd CV - (NCRI) is
Dr. Frances Shepherd CV - (NCRI) is
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2012 Royal College of Physicians and Surgeons of Canada Whiteman Award and V<strong>is</strong>iting<br />
Professorship<br />
2012 Queen Elizabeth II Jubilee medal<br />
10. RESEARCH GRANT SUPPORT LAST 5 YEARS: (Peer-reviewed, non-industry grants<br />
shaded in gray)<br />
RESEARCH AREA<br />
Genomic and Proteomic biomarkers<br />
of response to treatment with small<br />
molecule Epidermal Growth Receptor<br />
Inhibitors in non-small cell lung<br />
cancer<br />
Translating the results of clinical<br />
trials of radio/chemotherapy into<br />
improved health outcomes in the<br />
general population<br />
Phase III trial of Taxotere versus<br />
Iressa as second-line chemotherapy<br />
for non-small cell lung cancer<br />
INTEREST<br />
National Cancer Institute of Canada<br />
Clinical Trials Group<br />
Genomic biomarkers of response to<br />
treatment with erlotinib, a small<br />
molecule tyrosine kinase inhibitor of<br />
the epidermal growth factor receptor<br />
inhibitor in NSCLC<br />
A Phase randomized II trial of<br />
ZD6474 or placebo in responding to<br />
patients with SCLC<br />
National Cancer Institute of Canada<br />
Clinical Trials Group<br />
Phase III trial of Tarceva in 3 rd -line<br />
treatment of NSCLC<br />
Phase III trial of Taxotere +/-<br />
Topotecan in 2 nd -line NSCLC<br />
ROLE<br />
GRANTING<br />
AGENCY<br />
Co-investigator OCRN<br />
(03-APR-0324)<br />
Co-Investigator OCRN<br />
(02-NOV-0266)<br />
Local<br />
Principal<br />
Investigator<br />
<strong>Dr</strong>. Pater PI,<br />
<strong>Dr</strong>. <strong>Shepherd</strong><br />
PI for Lung<br />
Site<br />
Principal<br />
Investigator<br />
Local<br />
Principal<br />
Investigator<br />
<strong>Dr</strong>. Pater PI,<br />
<strong>Dr</strong>. <strong>Shepherd</strong><br />
PI for Lung<br />
Site<br />
Principal<br />
Investigator<br />
PERIOD<br />
FUNDING<br />
2003-2006 $526,560.00<br />
2004-2007 $848,643.60<br />
AstraZeneca 2004-2006 $190,000<br />
NCI-US 2004-2005<br />
2005-2006<br />
2006-2007<br />
2007-2008<br />
2008-2009<br />
Jacqueline<br />
Seroussi<br />
Memorial<br />
Foundation for<br />
Cancer Research<br />
$3,094,228<br />
$3,335,209<br />
$3,674,024<br />
$3,717,333<br />
$3,717,333<br />
2004-2006 $185,000<br />
NCIC-CTG 2003-2006 $36,000<br />
NCI Canada 2004<br />
2005<br />
2006<br />
2007<br />
2008<br />
$3,717,333<br />
$5,117,333<br />
$5,117,333<br />
$5,117,333<br />
$5,117,333<br />
NCIC CTG 2001-2004 $132,000 total<br />
Co-investigator Pfizer 2004-2006 $30,000<br />
3
Change language